Form4insider filings, from the source

SEC Form 4 · accession 0000899243-18-031217

FATE THERAPEUTICS INC · FATE

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Amir Nashat
Director
Period of report
Dec 13, 2018
Accepted (ET)
Dec 17, 2018 · 4:25 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001434316

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Dec 13, 2018S17,164$16.6721D1,948,494ISee Footnote
Common StockF1,F3Dec 13, 2018S334$16.6721D1,948,160ISee Footnote
Common StockF1,F4Dec 13, 2018S118$16.6721D1,948,042ISee Footnote
Common StockF1,F5Dec 13, 2018S172$16.6721D1,947,870ISee Footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses